The Mon Valley is getting an inpatient substance abuse treatment center, a rare service in Western Pennsylvania considering the size of the opioid problem.
Penn Highlands Mon Valley Hospital in Washington County will open a 14-bed inpatient addiction treatment unit after state inspections are done in the fall, hospital officials said. The unit, formally called the CNS Foundation Substance Recovery Unit, is the first of its kind in Fayette, Greene, Washington and Westmoreland counties and a rarity in a region where most addiction services are limited to outpatient therapy.
In the Pittsburgh area, only UPMC Mercy and McKeesport hospitals offer comparable Level 4.0 inpatient detoxification care for substance abuse and addiction, said Gopi Vadlamudi, medical director of the new unit.
“This is a disease for life,” said Dr. Vadlamudi, who is also a hospitalist caring for medical inpatients at Mon Valley. “There is a lot of need at this level.”
The new unit will provide withdrawal treatment for substance abuse combined with care for other medical problems that would not ordinarily be addressed in outpatient centers, Dr. Vadlamudi said. The new unit has been five years in the making, which included a review of overdose data in the Mon Valley.
Recruiting is underway for 20 addiction nurses and related job openings that are needed for the unit.
Read More
Overdose deaths in the U.S. hit a record in 2022 at 109,680, climbing 19% from 91,799 deaths in 2020, according to the Centers for Disease Control and Prevention. Washington County Coroner S. Timothy Warco reported 88 drug overdose deaths in 2022, down from 106 the previous year.
The number of overdose deaths in Pennsylvania — 5,092 between October 2021 and September 2022, according to the Hospital and Healthsystem Association of Pennsylvania — is overshadowed by the much larger number of people getting treated for opioid overdoses in hospital emergency rooms — 52,570 between January 2018 and July 2023, according to the state Department of Health.
Dr. Vadlamudi said the age of overdose survivors has been falling, even as the number of fatal overdoses overall decreases.
“Younger and younger folks are affected,” he said.
Newer drugs, such as non-opioid animal tranquilizer xylazine, have been showing up in overdose cases, which can cause chronic wounds that are slow to heal.
Cranberry-based Carelon Health of Pennsylvania, a diverse health services company founded in 2022, is overseeing the new unit at Mon Valley under contract agreement.
Physician Mark Fuller, former executive director of the Center for Recovery Medicine at Allegheny Health Network, serves as managed care medical director at Carelon.
Kris B. Mamula: kmamula@post-gazette.com




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.